CLINICAL_TRIALS
trial_result
· 2011-10-19
Clinical Trial Update: To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone [Phase 4]
Summary
Phase 4 trial update showing non-inferiority of the amlodipine/valsartan combination to valsartan alone in treating hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Hypertension, High Blood Pressure | Phase 4 | Status: COMPLETED | Results posted: 2011-10-19